BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36696451)

  • 21. The CCCTC Binding Factor, CTRL2, Modulates Heterochromatin Deposition and the Establishment of Herpes Simplex Virus 1 Latency
    Washington SD; Singh P; Johns RN; Edwards TG; Mariani M; Frietze S; Bloom DC; Neumann DM
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
    Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.
    Given D; Kieff E
    J Virol; 1978 Nov; 28(2):524-42. PubMed ID: 214576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.
    Ka-Yue Chow L; Lai-Shun Chung D; Tao L; Chan KF; Tung SY; Cheong Ngan RK; Ng WT; Wing-Mui Lee A; Yau CC; Lai-Wan Kwong D; Ho-Fun Lee V; Lam KO; Liu J; Chen H; Dai W; Lung ML
    EBioMedicine; 2022 Dec; 86():104357. PubMed ID: 36371985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer.
    Preston-Alp S; Caruso LB; Su C; Keith K; Soldan SS; Maestri D; Madzo J; Kossenkov A; Napoletani G; Gewurz B; Lieberman PM; Tempera I
    mBio; 2023 Oct; 14(5):e0039623. PubMed ID: 37606370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.
    Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H
    Front Immunol; 2020; 11():367. PubMed ID: 32194570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
    Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
    J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
    Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
    J Gen Virol; 2009 May; 90(Pt 5):1183-1189. PubMed ID: 19264589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
    Feederle R; Linnstaedt SD; Bannert H; Lips H; Bencun M; Cullen BR; Delecluse HJ
    PLoS Pathog; 2011 Feb; 7(2):e1001294. PubMed ID: 21379335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
    Higuchi H; Yamakawa N; Imadome KI; Yahata T; Kotaki R; Ogata J; Kakizaki M; Fujita K; Lu J; Yokoyama K; Okuyama K; Sato A; Takamatsu M; Kurosaki N; Alba SM; Azhim A; Horie R; Watanabe T; Kitamura T; Ando K; Kashiwagi T; Matsui T; Okamoto A; Handa H; Kuroda M; Nakamura N; Kotani A
    Blood; 2018 Jun; 131(23):2552-2567. PubMed ID: 29685921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.
    Correia S; Palser A; Elgueta Karstegl C; Middeldorp JM; Ramayanti O; Cohen JI; Hildesheim A; Fellner MD; Wiels J; White RE; Kellam P; Farrell PJ
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
    Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
    Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biogenesis of Epstein-Barr virus microRNAs.
    Kim DN; Lee SK
    Mol Cell Biochem; 2012 Jun; 365(1-2):203-10. PubMed ID: 22350759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
    Kang D; Skalsky RL; Cullen BR
    PLoS Pathog; 2015 Jun; 11(6):e1004979. PubMed ID: 26070070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics and Molecular Biology of Epstein-Barr Virus-Encoded BART MicroRNA: A Paradigm for Viral Modulation of Host Immune Response Genes and Genome Stability.
    Dreyfus DH
    J Immunol Res; 2017; 2017():4758539. PubMed ID: 28612032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin profiling of Epstein-Barr virus latency control region.
    Day L; Chau CM; Nebozhyn M; Rennekamp AJ; Showe M; Lieberman PM
    J Virol; 2007 Jun; 81(12):6389-401. PubMed ID: 17409162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.